ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Activity

44 hedge funds and large institutions have $2.43M invested in Eledon Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 7 closing their positions.

Holders
44
Holders Change
–
Holders Change %
0%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
19
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$327K
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$199K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$351K
4
State Street
4
State Street
Massachusetts
$136K
5
ARTA
5
A.R.T. Advisors
New York
$53K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
BCM
2
Bridgeway Capital Management
Texas
$98K
3
BFA
3
BlackRock Fund Advisors
California
$328K
4
SIM
4
Spark Investment Management
New York
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$20K
Name Market Value Shares Shares
Change 		Shares
Change %
LTFS
51
Ladenburg Thalmann Financial Services
Florida
$0 300 +300 New
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$0 333 +333 New
1 2
3